Collegium Pharmaceutical

COLLNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$955.823 M

$29.47 +1.24%

Close of 7 Aug 2026

Revenue

$780.6M

#1671 by revenue

Earnings

$63.0M

#1488 by earnings

Shares outstanding

32,555,613

Latest filing cover page

P/E ratio

15.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#165Janux TherapeuticsJANX$966.6M
#166OmerosOMER$959.0M
#167Collegium PharmaceuticalCOLL$955.8M
#168GeronGERN$950.9M
#169Amphastar PharmaceuticalsAMPH$916.3M

Where these numbers come from

Share counts and financials for Collegium Pharmaceutical are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.